Leading Cancer Hospitals in India for Nigerian Patients: How to Choose (2026)
Looking for cancer care in India? Here’s what Nigerian patients should consider when choosing a hospital, from specialists and technology to treatment and patient support.
Published on 23 September 202610m


India has leading cancer centres, and the one that suits you follows from your diagnosis rather than from a ranked list. Breast, prostate, cervical, colorectal and blood cancers are treated by different teams using different equipment, and a centre with a strong surgical oncology unit may not be where a lymphoma patient belongs. TMTC's
partner hospitals
include Fortis, Medanta, Artemis, MAX and Apollo, all JCI or NABH accredited. Ask which of them treats your specific cancer type and how often. This guide sets out how a Nigerian family should narrow the field: start with the diagnosis, then the treatment plan, then the hospital, and only then the flights.Key takeaways
- The diagnosis drives everything. Ask whether the Indian hospital will review your original biopsy slides and blocks rather than working from a report alone, because staging and pathology determine which centre and which protocol you need.
- Verify accreditation yourself on the JCI and NABH registries before sending records or paying a deposit anywhere, including to us.
- Cancer treatment usually runs over weeks or months rather than days, so the visa question for Nigerian patients is about duration and extension rather than speed.
- Nigeria is not on India's e-Visa eligibility list, so applications go on paper to the High Commission in Abuja or the Consulate General in Lagos, built around an invitation letter emailed by the Indian hospital directly to the mission.
Why the ranking question misleads
A ranked list measures institutional scale and reputation. Cancer care is decided by narrower things: whether the tumour board includes the disciplines your case needs, what radiotherapy technology the centre runs, how good its pathology is, and whether systemic therapy, surgery and radiation can be sequenced without you moving between institutions.
Two Nigerian patients illustrate the point. One has an early breast cancer needing surgery, then radiotherapy, then hormonal therapy over years. The other has an advanced head and neck cancer needing concurrent chemotherapy and radiation with a nutrition and airway plan alongside. Both need skilled care, and neither is well served by the same shortlist.
Start with the diagnosis, not the destination
Before choosing a hospital, get the diagnosis onto firm ground. That means the histopathology report, the slides and paraffin blocks from your biopsy, current imaging, and any molecular or receptor testing already done. Ask any Indian hospital whether its own pathologists will review that material rather than accept the report at face value, and ask what happens to the plan if their review differs.
This matters more than it sounds. Treatment intent, the order of surgery and systemic therapy, and sometimes the choice of centre all turn on the pathology. A plan built on an unreviewed report is a plan that may change after you arrive, with your visa dates and your money already committed.
Key point: Carry your original slides and blocks, not just the report, and confirm before you fly that the Indian hospital's laboratory will review them. Verify the hospital's JCI or NABH accreditation yourself on the published registries while you are at it, since that is the one claim you can check with certainty in advance.
The questions that narrow the list
| Ask the hospital | Why it matters |
|---|---|
| Does a multidisciplinary tumour board review cases like mine, and how often does it meet? | Cancer decisions made by one specialist alone are weaker than decisions made across surgery, medical oncology, radiation oncology and pathology |
| Will your pathologists review my slides and blocks? | Diagnosis and receptor status determine the whole protocol, and a revised diagnosis changes the plan |
| What radiotherapy equipment do you run, and is it available for the full course? | Technique and machine availability affect scheduling, which for a foreign patient affects how long you must stay |
| Can surgery, chemotherapy and radiotherapy all happen here? | Moving between institutions mid-protocol is where records, timing and costs come apart |
| How many patients with my tumour type and stage does the named consultant treat each year? | Volume in your specific disease matters more than the hospital's total admissions |
| What supportive care is in place if my counts drop or I develop an infection? | Systemic therapy complications are common and are managed well or badly |
| Will you provide a written protocol summary for my oncologist in Nigeria? | Continuity after you fly home determines what the treatment is worth |
What it costs, and why the number is a range
TMTC publishes base rates for surgical procedures, including US$3,000 for a mastectomy for breast cancer, with the company's own caveat that these are base rates and the final cost follows the treatment plan.
Cancer care resists a single figure more than any other field, because the plan is built in stages. Surgery can be quoted. Chemotherapy is priced by regimen and by cycle, and the number of cycles depends on how you respond. Radiotherapy is priced by technique and number of fractions. Supportive medication, transfusion support and imaging between cycles all add. Any provider quoting one number for a complete cancer treatment before the pathology is settled is quoting a guess.
What you should expect instead is a fixed itemised quote for the defined stage, issued after an online consultation with the treating Indian specialist, with the assumptions written down: which regimen, how many cycles, what happens if the protocol changes.
Patient tip: Ask what the quote covers per cycle and what the whole protocol would cost if you complete it as planned. Then ask what happens to both numbers if the tumour board changes the plan after your pathology review.
The Nigeria test: duration, not speed
For most treatments the Nigerian visa question is about how quickly a paper application can move. For cancer it is about how long the visa lasts, because chemotherapy and radiotherapy schedules run for weeks and often months.
Nigeria does not appear on the Government of India's
e-Visa eligibility list
, so the route is a paper Medical Visa at the High Commission in Abuja or the Consulate General in Lagos, with attendants applying separately under the Medical Attendant category. The application rests on an invitation letter from the Indian hospital naming you and your attendants with treatment dates, which the hospital must email directly to the mission.Two practical consequences follow. Ask the Indian hospital to state a realistic duration of treatment in that letter rather than the shortest defensible one, since the dates shape what you are granted. And if the protocol runs longer than expected, extensions are decided by the Foreigners Regional Registration Office in India on current hospital documentation, so raise it with your coordinator well before the visa expires rather than after.
Where cancer care happens in the TMTC network
TMTC's
partner hospitals
include Fortis, Medanta, Artemis, MAX and Apollo, all JCI or NABH accredited, with sites across Delhi NCR, Bengaluru, Mumbai, Hyderabad, Pune and Surat, so the city follows from the case rather than the reverse. Ask which of them treats your specific diagnosis, and how many patients with it they see.You can review the
specialists
before committing to an institution. Every recommendation is reviewed by TMTC's Medical Director of Primary Care, a UK-registered GP, giving the plan an additional layer of independent UK clinical oversight. That review covers continuity and the interpretation of your records rather than the treatment itself, which remains the oncology team's work.Recovery, insurance and going home
Cancer treatment does not end at discharge, and the handover home is the part that decides whether the trip holds its value. Our patients stay at the
aftercare centre
, where a doctor and nurse are on site around the clock, physiotherapy runs daily and meals are designed by a nutritionist, until a clinician certifies them fit to fly.The
post-treatment insurance
included in the package covers the flight back to India and treatment in India if a complication arises, rather than treatment in Nigeria, which is a real limit and worth reading in the policy itself. You travel home with a discharge summary, your imaging and pathology, a written protocol summary, structured remote follow-up, and coordination with your own oncologist in Lagos, Abuja, Port Harcourt or wherever you live, since that clinician manages your surveillance for years.Settle the Diagnosis, Then Choose
The order matters more than the shortlist. Confirm the pathology, get it reviewed, let the tumour board set the plan, and let the plan tell you which hospital and how long you will be away. A centre that will review your slides, name its consultant's experience in your specific disease, and put its assumptions in writing belongs on your list regardless of where anyone ranks it. If you would like that sequence handled alongside the visa work, a
free consultation
is where TMTC's Nigeria service
begins.Frequently asked questions
Which cancer hospital in India is right for Nigerian patients?
It depends on your tumour type, stage and the treatment your case needs, which is why the diagnosis has to come before the shortlist. Verify JCI or NABH accreditation, ask about the tumour board and the consultant's experience in your specific disease, then compare two or three.
Should I bring my biopsy slides to India?
Yes. Bring the original slides and paraffin blocks along with the report and your imaging, and confirm in advance that the Indian hospital's pathologists will review them. A revised pathology reading can change the treatment plan, the centre and the length of your stay.
How much does cancer treatment in India cost for Nigerians?
TMTC publishes base rates for surgical procedures, including US$3,000 for a mastectomy. Chemotherapy and radiotherapy are priced by regimen, cycles and technique, so expect an itemised quote covering a defined stage of treatment rather than a single figure for everything at once.
How long will I need to stay in India?
Longer than for most other treatments, because chemotherapy and radiotherapy schedules run over weeks or months rather than days. Ask the Indian hospital to state a realistic duration in the invitation letter, since those dates shape the visa validity you are granted and a plan that assumes the shortest possible course creates problems later.
What if my treatment runs past my visa?
Extensions are decided by the Foreigners Regional Registration Office in India, on current documentation from your treating hospital rather than by the mission in Nigeria. Raise it with your coordinator as soon as the protocol changes and well before the visa expires, since late applications create avoidable difficulty.
Sources referenced for this guide: The Medical Travel Company published service pages, partner hospitals and Nigeria market rates; Government of India e-Visa portal, eligibility list; High Commission of India, Abuja, medical visa requirements; Joint Commission International and National Accreditation Board for Hospitals and Healthcare Providers accreditation registries.
Please note: Visa requirements, fees and arrangements change from time to time. Confirm the current position with the relevant mission or official portal before booking travel or committing to treatment.
Disclaimer. This article is for general information only and is not medical advice. It does not replace consultation with a qualified doctor. Treatments, risks, recovery and outcomes vary by individual and depend on your personal circumstances; speak to a registered clinician before making any treatment decision. Insurance cover, including any post-treatment cover, is subject to the full terms, limits and exclusions of the policy document, which is provided before you book.
Ready to open the door to better health?
